Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
At our annual MIT Startup Ecosystem Conference, we celebrate innovation and bring together its many contributors: entrepreneurs, corporates, and university researchers, as well as government representatives, investors, and those involved with incubators and accelerators. We will assemble to discuss creating, supporting, and scaling new ventures and how to increase productivity and competitive advantage. Aligned with the emphasis of MIT Startup Exchange, we will focus on the startup-corporate relationship. Topics will include pain points, valleys of death, and strategies to avoid as well as how to overcome the stones found along the way.
As always, this event features executives from some of the most promising startups connected to MIT who will present lightning talks in two fast-paced sessions, each followed by an opportunity to have direct discussions.
Many consider this conference a must-attend for innovators and executives at industry-leading corporations, especially those working in innovation, emerging technology, corporate venture capital, and/or corporate development/strategy.
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Early-stage startups are invited to MIT.nano to learn more about the START.nano program and explore how its state-of-the-art laboratories can support their growth.
R&D Conference is our biggest conference of the year. We're looking for 10 speakers/exhibitors.
MassRobotics, in collaboration with Festo, Mitsubishi Electric, Novanta, and MITRE, is now accepting application for the 2025-2026 Healthcare Robotics Startup Catalyst Program. Startups can apply now through December 1, 2025.
This forum will bring together senior executives with thought leaders from MIT to explore the best methods for creating and organizing corporate innovation and venturing groups. We will also discuss how the MIT Industrial Liaison Program (ILP) helps firms engage with the world-leading thinkers at MIT who tackle humanity's most vexing challenges and the entrepreneurs who turn MIT innovations into working solutions.
P&G Ventures is looking for startup submissions on disruptive solutions in women's wellness. P&G is on a mission to help women (18+) optimize/enhance their health and wellness by (a) creating products that are designed specifically for women, (b) address gaps in her self-care and (c) offer meaningful difference in her life. We will start by addressing frequent, daily fatigue that negatively impacts her day, her capacity and ultimately her relationships.
The annual MIT Startup Ecosystem Conference features 25 of the most promising startups from across MIT. These startups are all part of STEX25, an accelerator run by MIT Startup Exchange, an integrated program of MIT Corporate Relations.